Novalgen

Website

Developer of comprehensive immunotherapy platform designed to make biological medicines. The company's platform develops breakthrough bispecific antibody therapies that can safely harness the immune s...

Healthcare
London, United Kingdom
Founded 2018
14 employees
Website
Valuation
$38M
Market implied
Share Price
N/A
Total Raised
$40.4M
Last Round
N/A
Investors
+7 other investors
View all 7 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Novalgen's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required